1. Introduction
===============

The identification of a novel coronavirus as the causative agent of the severe acute respiratory syndrome (SARS) has led to a renewed interest in coronaviruses ([@bib25]). Coronaviruses are large, enveloped single-stranded positive sense RNA viruses with a genome of approximately 30 kb in length, the largest found in any of the RNA viruses. Coronaviruses are classified into three groups based on genetic and serological relationships ([@bib9]). The feline infectious peritonitis virus (FIPV) belongs to group 1 and the SARS-CoV is not assigned to any of these groups but is most closely related to group 2 coronaviruses.

Until now five human coronaviruses are known to cause respiratory tract illnesses. HCoV-OC43 and HCoV-229E are responsible for 10--30% of all common colds, and infections occur mainly during the winter and early spring ([@bib19]). During the 2002--2003 winter season, a new human coronavirus, HCoV-NL63, was isolated in The Netherlands ([@bib30]). The recurrent detection of HCoV-NL63 in patient samples worldwide indicates that HCoV-NL63 can be considered as a new important etiologic agent in respiratory tract infections ([@bib1], [@bib6], [@bib22]). The fifth human coronavirus, HCoV-HKU1 was discovered in 2004 by a Chinese group ([@bib32]). Since then, this new coronavirus was additionally detected in Australia and France, suggesting a worldwide spread ([@bib26], [@bib27]).

Before the emergence of SARS-CoV, coronavirus research was focused on the veterinary field, where coronaviruses cause devastating epizootics of respiratory or enteric diseases in livestock and poultry. In cats, two coronaviruses are described, the feline infectious peritonitis virus (FIPV) and feline enteric coronavirus (FECV). These feline coronaviruses are spread worldwide and infect domestic cats and other members of the *Felidae* family. An infection with FECV is usually subclinical, except in young kittens where it may cause mild to severe diarrhea ([@bib24]). In contrast, FIPV infection causes a chronic and very often fatal peritonitis which is the most important cause of death of infectious origin in cats.

Lectins are natural proteins that target the sugar moieties of a wide variety of glycoproteins. They are widespread among higher plants and are subdivided into seven families of structurally and evolutionarily related proteins ([@bib28]). More than a decade ago, plant lectins were reported to inhibit HIV replication in lymphocyte cell cultures through inhibition of virus-cell fusion ([@bib2], [@bib20], [@bib10], [@bib11]). Plant lectins are carbohydrate-binding proteins capable of specific recognition and reversible binding to carbohydrates. Initially, it was reported that plant lectins inhibit virus replication by preventing virus adsorption ([@bib23]), but it was later shown that they prevent fusion of HIV particles with their target cells ([@bib2], [@bib3]). In addition to the antiviral effect of mannose- and *N*-acetylglucosamine-specific agglutinins on HIV, an inhibitory effect of these plant lectins was reported on cytomegalovirus infection, respiratory syncytial virus infection and influenza A virus infection *in vitro* ([@bib2], [@bib3], [@bib4]). The SARS-CoV spike protein is heavily glycosylated and contains 23 putative *N*-glycosylation sites, among which 12 have been described to be effectively glycosylated ([@bib18]). One may therefore expect coronavirus infectivity to be inhibited by those lectins that are specific for the glycans present in the spike glycoprotein.

In the present study, we evaluated a panel of 33 carbohydrate-binding proteins, containing mannose, *N*-acetyl glucosamine, glucose, galactose, and *N*-acetyl galactosamine specific plant lectins, for their activity against SARS-CoV and FIPV infection *in vitro*. We demonstrate that the most pronounced anti-coronavirus activity was found mainly among the mannose-binding lectins. Two targets of possible antiviral intervention in the replication cycle of SARS-CoV have been identified.

2. Materials and methods {#sec1}
========================

2.1. Test compounds
-------------------

The origin and sugar-specificity of the plant lectins used in our study are listed in [Table 1](#tbl1){ref-type="table"} . All plant lectins were kindly provided by Prof. Van Damme (University of Gent, Belgium) and were purified as described before ([@bib28], [@bib29], [@bib7], [@bib31]). The mannose specific lectin *Hippeastrum hybrid* agglutinin (HHA) was used in the further mechanism of action studies, because of the its availability and its relative good anti-coronavirus activity.Table 1Plant lectins tested for their antiviral activity against SARS-CoV and FIPVLectinPlant speciesCommon nameTaxonomyReferenceMan-specific agglutinins HHA*Hippeastrum hybrid*AmaryllisMonocot, Amaryllidaceae[@bib28] GNA*Galanthus nivalis*SnowdropMonocot, Amaryllidaceae[@bib28] NPA*Narcissus pseudonarcissus*daffodilMonocot, Amaryllidaceae[@bib28] LRA*Lycoris radiata*Red spider lilyMonocot, Amaryllidaceae[@bib28] APA*Allium porrum*LeekMonocot, Alliaceae[@bib28] AUA*Allium ursinum*RamsonsMonocot, Alliaceae[@bib28] ASA*Allium sativum*GarlicMonocot, Alliaceae[@bib28] ASA I*Allium sativum*GarlicMonocot, Alliaceae[@bib28] Col O*Colocasia esculenta*TaroMonocot, Araceae[@bib28] CA*Cymbidium hybrid*Cymbidium orchidMonocot, Orchidaceae[@bib28] LOA*Listera ovata*TwaybladeMonocot, Orchidaceae[@bib28] EHA*Epipactis helleborine*Broad-leaved helleborineMonocot, Orchidaceae[@bib28] TL M I*Tulipa hybrid*TulipMonocot, Liliaceae[@bib28] Morniga M II*Morus Nigra*Black mulberry treeDicotyl, Moraceae[@bib29]  GlcNAc-specific agglutinins PallGlcNac*Phragmites australis*Common reedMonocot, Gramineae[@bib28] Nictaba*Nicotiana tabacum*Tabacco plantDicot, Solanaceae[@bib7]  (GlcNAc)~*n*~-specific agglutinins UDA*Urtica dioica*Stinging nettleDicot, Urticaceae c[@bib28] Heveine*Hevea brasiliensis*Rubber treeDicot, Euphorbiaceae[@bib28]  GalNAc-specific agglutinins PMRIP t*Polygonatum multiflorum tetramer*Solomon\'s sealMonocot, Liliaceae[@bib28] BDA*Bryonia dioica*White bryonyDicot, Curcurbitaceae[@bib28] Glechoma*Glechoma hederacea*Ground ivyDicot, Lamiaceae[@bib31]  Gal-specific agglutinins Morniga G II*Morus Nigra*Black mulberry treeDicot, Moraceae[@bib29] Jacalin*Artocarpus integrifolia*JackfruitDicot, Moraceae[@bib28]  Neu5Acα(2.6)Gal/GalNAc-specific agglutinins SNA I*Sambucus nigra*ElderberryDicot, Sambucaceae[@bib28]  Man/Glc-specific agglutinins Cladistris*Cladastris lutea*Yellow woodDicot, Fabaceae[@bib28]  Gal/GalNAc specific agglutinins PMRIP m*Polygonatum multiflorum monomer*Solomon\'s SealMonocot, Liliaceae[@bib28] ML II*Viscum album*MistletoeDicotyledoneae, Viscaceae[@bib28]  GalNAc (\>Gal) specific agglutinins ML III*Viscum album*MistletoeDicotyl, Viscaceae[@bib28]  GalNAcα(1,3)Gal \> GalNAc \> Gal-specific agglutinins IRA*Iris hybrid*IrisMonocot, Iridaceae[@bib28] IRA b*Iris hybrid*IrisMonocot, Iridaceae[@bib28] IRA r*Iris hybrid*IrisMonocot, Iridaceae[@bib28]  Man/GalNAc-specific agglutinins TL C II*Tulipa hybrid*TulipMonocot, Liliaceae[@bib28][^1]

2.2. Cells and virus
--------------------

The SARS-CoV Frankfurt 1 strain was kindly provided by Prof. Dr. Rabenau from the Johann Wolfgang Goethe University, Frankfurt, Germany. Vero E6 cells ATCC were propagated in minimal essential medium (MEM; Gibco, Life Technologies, Rockville, MD) supplemented with 10% fetal calf serum (FCS; Integro, Zaandam, The Netherlands), 1% [l]{.smallcaps}-glutamine (Gibco, Life Technologies, Rockville, MD), and 0.3% sodium bicarbonate (Gibco, Life Technologies, Rockville, MD). Virus-infected cells were maintained at 37 °C in 5% CO~2~ in MEM supplemented with 2% FCS. The isolation of FIPV strain 79-1146 was previously described by McKeirnan and co-workers ([@bib21]). Crandell-Reese feline kidney (CrFK) cells were maintained in RPMI-1640 medium (Gibco) supplemented with 10% fetal calf serum (Harlan Sera-Lab Ltd., Loughborough, UK), 2 mM [l]{.smallcaps}-glutamine (Gibco), and 0.075% sodium bicarbonate (Gibco). Virus-infected cells were maintained at 37 °C in RPMI-1640 medium supplemented with 2% FCS.

2.3. Virus handling and titration
---------------------------------

SARS-CoV culture and assays were carried out in a biosafety level-3 laboratory at the University of Leuven, according to the conditions set out in 'Biosafety in Microbiological and Biomedical Laboratories' ([@bib12]). FIPV was handled in a biosafety level-2 laboratory. The virus titer in the frozen culture supernatant was determined by using a cytopathicity (CPE)-based assay. Briefly, 100 μl of virus in 10-fold serial dilution was added, in quadruplicate, to a subconfluent monolayer of Vero E6 (for SARS-CoV) or CrFK (for FIPV) cells in a 96-well plate. After 3 days of incubation for SARS-CoV, the cells were visually scored for virus-induced CPE. After 4 days of incubation for FIPV, the viability of the virus-infected cells was scored by the tetrazolin-based colorimetric method as described before (Balzarini et al., Antiviral Res., in press, 2006). The limiting dilution end point (CCID~50~/ml) was determined by the Kärber equation ([@bib14]).

2.4. Antiviral assay
--------------------

Antiviral activity and cytotoxicity measurements were based on the viability of Vero E6 cells that had been infected (or mock-infected) with 100 CCID~50~ (50% cell culture infective doses) of the SARS-CoV ([@bib15]) and CrFK cells infected (or mock-infected) with 100 CCID~50~ of FIPV in the presence of various concentrations of the test compounds. Three days (SARS-CoV) or 4 days (FIPV) after infection, the number of viable cells was quantified by a tetrazolium-based colorimetric method, in which the reduction of the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2*H*-tetrazolium (MTS) dye (CellTiter 96 AQueous One Solution kit, Promega, The Netherlands) by mitochondrial dehydrogenases to a soluble colored formazan was measured in a spectrophotometer (Multiskan EX, Thermo Labsystems, Belgium) at 492 nm. The cytotoxic concentration was defined as the concentration of the compound that reduced cell viability by 50% \[50% cytotoxic concentration (CC~50~)\], and the antiviral effective concentration was defined as the compound concentration that suppressed the viral cytopathic effect by 50% \[50% effective concentration (EC~50~)\].

2.5. Real-time RT-PCR
---------------------

The methodology of the real-time RT-PCR assay has been described previously ([@bib17]). Briefly, a real-time quantitative RT-PCR was designed to measure copies of the replicase 1B gene of the SARS-CoV genome. Primers spanning a target region of 68 bp were selected: forward primer SARS-FP (5′-CACCCGCGAAG-AAGCTATTC-3′), MGB probe SARS-TP (FAM 5′-TGCGTGGATTGGCTT-3′NFQ-MGB), and reverse primer SARS-RP (5′-TTGCATGACAGCCCTCTACATC-3′). A 25 μl RT-PCR was carried out using 5 μl of extracted RNA or standard cRNA, 12.5 μl of one step RT qPCR Mastermix containing ROX as a passive reference (Eurogentec, Seraing, Belgium), 900 nM forward and reverse primer, and 150 nM minor groove binding probe. Amplification and detection were performed in a ABI PRISM 7700 Sequence Detection System (Applied Biosystems, Foster City, CA, USA) under the following conditions: an initial reverse transcription at 48 °C for 30 min, followed by PCR activation at 95 °C for 10 min and 45 cycles of amplification (15 s at 95 °C and 1 min at 60 °C). The threshold cycle represented the refraction cycle number at which a positive amplification was measured, and was set at 10 times the standard deviation of the mean baseline emission calculated for PCR cycles 3--15.

2.6. Time-of-addition assay
---------------------------

Subconfluent monolayers of Vero E6 cells in 96-well plates were infected with 1000 CCID~50~ SARS-CoV. After 20 min of adsorption, cell monolayers were washed five times with PBS. HHA was added in triplicate at a concentration 10-fold above the EC~50~ (i.e. 32 μg/ml), at the time of infection or at a variety of different time points thereafter. Eight hours after infection, a time at which the first viral cycle has already been completed ([@bib16]), supernatants and cells were collected. Viral RNA was extracted using the QIAamp viral RNA kit and Rneasy minikit (Qiagen), respectively to determine the viral RNA-load in the cell supernatant and intracellularly by using the quantitative RT-PCR described above.

2.7. Pre-exposure of cell-free SARS-CoV to the plant lectins prior to infection
-------------------------------------------------------------------------------

In a first set of experiments, a concentrated cell-free SARS-CoV preparation (50 μl) was exposed to 50 μl of 1280, 512, 205, and 82 μg of HHA per ml for 2 h at room temperature (final lectin concentrations of 640, 256, 120, and 41 μg/ml). Then, the drug-exposed virus suspension was diluted such that a final 1000-fold dilution of virus and lectin were used to inoculate Vero E6 cell cultures (1 × 10^4^  cells/well). At day 3 post-infection, virus-induced destruction of the Vero E6 cell cultures was quantified as described above.

2.8. Pre-exposure of Vero E6 cells to the plant lectins prior to infection
--------------------------------------------------------------------------

Vero E6 cells seeded in 96-well plates were pre-exposed to final HHA concentrations of 640, 256, 64, and 26 μg/ml for 2 h. Then, cell monolayers were washed five times with 200 μl phosphate-buffered saline (PBS). Next, the cells were infected with 100 CCID~50~ SARS-CoV. At day 3 post-infection, the antiviral activity of the plant lectins was determined as described above.

2.9. Virus entry assay
----------------------

In this assay the inhibitory effects of HHA on virus entry into Vero E6 cells were measured. Therefore, Vero E6 cells (1 × 10^5^  cells/well in a 24 well plate) were incubated with 100 CCID~50~ SARS-CoV in the absence or presence of serial dilutions of the test compound. Two experiments were performed in parallel. In the first setting, the compound was present only during virus attachment (incubation for 60 min at 4 °C). In the second setting, the compound was present during virus attachment and penetration (incubation for 60 min at 37 °C). After this initial incubation, both settings underwent the same procedure. Cells were washed five times with PBS in order to remove the unadsorbed virus particles and the test compound. Subsequently, the 24 well plates were incubated at 37 °C. Eight hours after infection the cells were subjected to a freeze-thaw cycle and cell lysates were collected. Viral RNA was extracted using the QIAamp viral RNA kit and subsequently viral RNA-load quantification was elaborated by using the quantitative RT-PCR described above.

3. Results
==========

3.1. Antiviral activity of plant lectins
----------------------------------------

A broad range of plant lectins with different specificities were evaluated in a colorimetric cell culture-based assay for their antiviral activity against coronaviruses, namely the SARS-CoV and FIPV. The antiviral activities, represented by their 50% effective concentration or EC~50~, and the cytotoxic activity in Vero and CrFK cells, represented by their 50% cytotoxic concentration or CC~50~ are shown together with the sugar specificity of the different plant lectins in [Table 2](#tbl2){ref-type="table"} . Out of the 33 plant lectins tested against SARS-CoV and FIPV, 15 lectins had antiviral properties against both Coronaviruses; 5 plant lectins were active only against SARS-CoV and 2 lectins showed solely activity against FIPV. Eight lectins were inactive against both SARS-CoV and FIPV. All mannose-binding lectins, except for the lectins isolated from garlic, had anti-coronavirus properties. Cytotoxicity in Vero and CrFK cells was measured in parallel with the determination of the antiviral activity. In general, plant lectins were more toxic to CrFK cells than to Vero E6 cells. The most potent lectin against the SARS-CoV-induced cytopathicity is the mannose-specific plant lectin isolated from leek (APA) with an EC~50~ of 0.45 μg/ml and a selectivity index of \>222. In addition, the *N*-acetyl glucosamine-specific lectins isolated from the stinging nettle (UDA) and from the tobacco plant (Nictaba) are also markedly active against the SARS-CoV with a selectivity index of \>77 and \>59, respectively. For FIPV, the most active lectin is the mannose-specific lectin isolated from the twayblade (LOA) with an EC~50~ of 0.7 μg/ml and a selectivity index of \>143 ([Table 1](#tbl1){ref-type="table"}).Table 2Antiviral activity of plant lectins against SARS-CoV and FIPV replication in Vero and Crandell Feline kidney cellsLectinSARS-CoVFIPVEC~50~ (μg/ml)CC~50~ (μg/ml)SIEC~50~ (μg/ml)CC~50~ (μg/ml)SIMannose-specific agglutinins HHA3.2 ± 2.8\>100\>31.32.6 ± 1.0\>100\>38.5 GNA6.2 ± 0.6\>100\>16.13.9 ± ±2.2\>100\>25.6 NPA5.7 ± 4.4\>100\>17.524 ± 5\>100\>4.2 LRA48\>100\>2.1ind\>20na APA0.45 ± 0.08\>100\>222.22.0 ± 0.317 ± 48.5 AUA18 ± 4\>100\>5.516 ± 5\>100\>6.2 ASA\>100\>100na\>100\>100na ASA I\>100\>100na\>100\>100na Col O\>6063 ± 3na2.5 ± 0.612 ± 04.8 CA4.9 ± 0.8\>100\>204.5 + 2.6\>50\>22 LOA2.2 ± 1.3\>100\>45.50.7 ± 0.3\>100\>142.8 EHA1.8 ± 0.3\>100\>55.51.6 ± 0.9\>100\>62.5 TL M I22 ± 6\>50\>2.3ind\>50na Morniga M II1.6 ± 0.5\>100\>62.52.9 ± 0.011 ± 13.8  GlcNAc-specific agglutinins PallGlcNac\>100\>100na\>2057 ± 1na Nictaba1.7 ± 0.3\>100\>58.84.3 ± 1.9\>100\>23.2  (GlcNAc)~*n*~-specific agglutinins UDA1.3 ± 0.1\>100\>76.93.6 ± 2.315 ± 144.16 Heveine\>100\>100na\>100\>100na  GalNAc-specific agglutinins PMRIP t\>100\>100na\>100\>100na BDA\>100\>100na\>100\>100na Glechoma\>100\>100na\>100\>100na  Gal-specific agglutinins Morniga G II50 ± 13\>100\>211 ± 2\>100\>9.1 Jacalin\>100\>100na25 ± 2\>100\>4  Neu5Acα(2.6)Gal/GalNAc-specific agglutinins SNA I\>100\>100na\>100\>100na  Man/Glc-specific agglutinins Cladistris7.4 ± 0.2\>100\>13.517 ± 6\>100\>5.9  Gal/GalNAc specific agglutinins PMRIP m18 ± 13\>100\>5.560 ± 5\>100\>1.7 ML II0.015 ± 0.003 \< 0.16na\>0.0080.0022 ± 0.005na  GalNAc (\>Gal) specific agglutinins ML III28 ± 11\>100\>12.6\>100\>100na  GalNAcα(1,3)Gal \> GalNAc \> Gal-specific agglutinins IRA2.2 ± 0.95022.7\>20\>20na IRA b4.4 ± 3.1368.2\>0.160.55 ± 0.23na IRA r3.4 ± 2.05516.2\>0.160.49 ± 0.28na  Man/GalNAc-specific agglutinins TL C II38 ± 0\>50\>1.321 ± 1\>50\>2.4[^2]

3.2. Antiviral activity of the mannose-specific lectin of amaryllis (HHA) administered at different time points after coronavirus infection
-------------------------------------------------------------------------------------------------------------------------------------------

A time-of-addition assay was performed using the mannose-specific lectin of amaryllis (HHA) to determine its efficacy when added at various times after virus infection. For this purpose, Vero E6 cells were infected with 1000 CCID~50~ SARS-CoV. The virus was allowed to perform a single cycle of replication. The HHA concentration, which is 10 times the EC~50,~ was added at different time points after infection. Viral RNA levels in the cell supernatants and in the cells were determined 8 h post-infection. The measurement of the intracellular viral load shows that the lectins are required at the moment of infection to block the SARS-CoV replication ([Fig. 1](#fig1){ref-type="fig"} ). When HHA was added at the time of infection, intracellular RNA could still be detected but the viral load was one log reduced in comparison to the positive control. The extracellular viral load determinations indicate that addition of the lectins to SARS-CoV-infected cells could be delayed up to 5 h without a significant loss of antiviral activity ([Fig. 2](#fig2){ref-type="fig"} ).Fig. 1Intracellular SARS-CoV replication in Vero E6 cells after treatment with HHA concentrations at different time points post-infection (■). Vero E6 cells were infected with 1000 CCID~50~ SARS-CoV FFM-1 at different time-points post-infection HHA (32 μg/ml) is added to the infected cells. The virus control represents infected cells incubated with medium (□). Eight hours after infection, cell supernatants were collected and viral RNA was extracted and quantified by qRT-PCR as described in Section [2](#sec1){ref-type="sec"}. Data are mean values ± S.E.M. of at least three replicates.Fig. 2Extracellular SARS-CoV replication in Vero E6 cells after treatment with HHA at different time points post-infection (■). Vero E6 cells were infected with 1000 CCID~50~ SARS-CoV FFM-1 at different time-points post-infection HHA (32 μg/ml) is added to the infected cells. The virus control represents infected cells incubated with medium (□). Eight hours after infection, cell supernatants were collected and viral RNA was extracted and quantified by qRT-PCR as Section [2](#sec1){ref-type="sec"}. Data are mean values ± S.E.M. of at least three replicates. The dotted line represents the residual background of viral load, that was detected after washing the cells.

3.3. Virucidal properties of HHA
--------------------------------

In order to investigate possible virucidal properties of the plant lectins, two experiments were conducted. In a first set of experiments, the cell-free SARS-CoV was exposed for 2 h to the plant lectin HHA at ca. 200-, 80-, 20-, and eight-fold its EC~50~ concentration (i.e. 640, 256, 102.4, and 41 μg/ml). The drug-exposed virus preparation was then diluted 1000-fold before being used to infect Vero E6 cells. Although reduced infectivity was seen with the highest HHA concentration (i.e. 640 μg/ml), this antiviral effect can not be ascribed to the pre-exposure of the virus to the plant lectin HHA, but was a result of the residual HHA concentration of 0.64 μg/ml, which is only five times below the EC~50~ and offers background protection against viral induced CPE. Thus, pre-exposure of the virus preparations to HHA did not affect the viral replication capacity in the Vero cell cultures. Similarly pre-exposure of the Vero E6 cells, instead of the virus, to the lectins revealed no significantly increased protective activity of the lectins against the virus-induced cytopathicity in pre-treated Vero E6 cells as compared to the SARS-CoV-infected cell cultures that were not pre-incubated with the lectins (data not shown).

3.4. Virus entry assay
----------------------

To further characterize the mode of action of HHA on its anti-SARS-CoV activity, a virus entry assay was performed. Incubating cells and virus at a low temperature (4 °C), allows most virions to irreversibly attach to the cells, but not penetrate. In a second setting, where cells, compound and virus were incubated for 60 min at 37 °C, both attachment and penetration are achieved. After this initial incubation at 4 °C or at 37 °C, cells were extensively washed with PBS to eliminate residual HHA and unadsorbed virus. Subsequently, the temperature was raised immediately to 37 °C. Results demonstrate that in both situations, HHA showed antiviral activity ([Fig. 3](#fig3){ref-type="fig"} ). Moreover, when a slower and irreversible attachment was achieved at 4 °C, HHA was two times more active (EC~50~  = 2.5 μg/ml) in comparison to the situation when both attachment and penetration could occur at 37 °C (EC~50~  = 5.2 μg/ml).Fig. 3The inhibitory effects of HHA on virus adsorption to Vero E6 cells are presented as percent protection. Two experiments were performed in parallel. In the first setting (white bars), the compound was present only during virus attachment. In the second setting (black bars), the compound was present during virus attachment and penetration. Data are mean values ± S.E.M. of four replicates.

4. Discussion
=============

The antiviral activity spectrum of plant lectins varies considerably, depending on the nature of their sugar specificity. In general, the mannose-specific plant lectins are highly effective against coronaviruses. It is also possible that plant lectins with different specificity interfere with different targets necessary for viral entry, depending on the place of the glycans that are targeted. For HIV, it was recently demonstrated that plant lectins with different carbohydrate specificities, i.e. mannose-specific versus *N*-acetylglucosamine-specific, represent carbohydrate-binding agents with a similar mode of antiviral action, but with different genetic barriers ([@bib5]).

Out of 33 plant lectins evaluated, 15 showed antiviral properties against both SARS-CoV and FIPV, and 8 plant lectins showed no anti-coronavirus activity. The lectins with anti-coronaviral activity included mannose-, glucose-, galactose-, *N*-acetyl glucosamine- and *N*-acetyl galactosamine-specific agglutinins In general plant lectins were more toxic to CrFK cells than to Vero E6 cells. This could partly explain some differences between the SARS-CoV activity and FIPV activity of plant lectins. Most of the lectins that were not active against FIPV were too toxic for the CrFK cells. The most prominent anti-coronavirus activity was found among the mannose-specific plant lectins. In the SARS-CoV spike protein there are 12 *N*-glycosylation sites. The sugars attached to four of these *N*-glycosylation sites have been identified ([@bib18]). Two of the four sugars were found to be high-mannose type glycans, whereas the other two showed complex glycan structures ([@bib18]). The presence of high-mannose type glycans can explain the potent anti-SARS-CoV activity of mannose-specific plant lectins. When we compare the activity spectrum of the plant lectins against coronaviruses with their activity spectrum against HIV, only the mannose-specific plant lectins, with the exception of UDA, which is a *N*-acetyl glucosamine-specific lectin, possess antiviral activity against HIV ([@bib2], [@bib3]). Thus, the carbohydrate spectrum of plant lectins that inhibit virus infection is broader for coronaviruses than for HIV.

Calculation of the correlation coefficient between the EC~50~ values of the plant lectins against SARS-CoV on the one hand, and the EC~50~ values of the compounds against FIPV on the other hand, resulted in an *r*-value of 0.38. When only the active mannose-specific lectins were taken into account, a much higher *r*-value of 0.70 was calculated ([Fig. 4](#fig4){ref-type="fig"} ). Furthermore, a marked correlation was found when the correlation coefficient between the anti-HIV activity of the plant lectins ([@bib2], [@bib3]), and their anti-FIPV or anti-SARS-CoV activity was calculated (*r*-values were found to be 0.55 and 0.52, respectively).Fig. 4Calculation of the correlation coefficient between the EC~50~ values of the plant lectins against SARS-CoV on the one hand, and the EC~50~ values of the compounds against FIPV on the other hand, resulted in an *r*-value of 0.38. When only the active mannose-specific lectins were taken into account, an *r*-value of 0.70 was found.

Plant lectins are known to possess virucidal properties against HIV, and may therefore qualify as HIV microbicides ([@bib4]). In contrast to HIV, the plant lectins did not show marked virucidal properties against the SARS-CoV, neither when they were pre-incubated with the cells, nor when pre-incubated with the virus. This can be due to a lower binding affinity (on-rate) of the plant lectins to the coronavirus envelope glycans and/or a faster off-rate of the plant lectins from the coronavirus envelope glycans.

To elucidate the mechanism of antiviral intervention of the plant lectins, a time-of-addition assay was elaborated using the mannose-specific lectin of the amaryllis (HHA). The lectin was added to the infected cell cultures at different time-points post-infection. At 8 h post-infection, the SARS-CoV viral load was quantified intracellularly and extracellularly. A marked difference was noted between these two measurements. The intracellular viral RNA-load could only be efficiently reduced when the lectin was added at the time of infection, indicating that the plant lectins interact with an early step in the viral replication cycle. In general, the SARS-CoV entry starts with the attachment of the virus to its specific receptor ACE2 on the cell surface. The receptor binding subsequently induces the viral envelope protein to undergo conformational changes that mediate fusion between the viral and cellular membranes ([@bib8]). The coronavirus spike glycoprotein is responsible for these two steps in the coronavirus entry process. Since each step of the viral entry pathway is a potential target for antiviral agents, entry inhibitors fall into several categories. A first class consists of inhibitors that bind to the ACE2 receptor, a second category comprises entry inhibitors that bind to the virus and prevent it from interacting with its receptors and a third group of inhibitors can hamper the conformational changes, resulting in the inhibition of SARS-CoV fusion with the target cell. In order to distinguish between these categories of entry inhibitors more in-depth studies were conducted. The virus entry assay showed that HHA was active when incubating the cells and virus at 4 °C. This low temperature incubation allows most virions to irreversibly attach to the cells, but not to penetrate the cells. Moreover, when this slower and irreversible attachment was achieved at 4 °C, HHA was two times more active (EC~50~  = 2.5 μg/ml) in comparison to attachment and penetration at 37 °C (EC~50~  = 5.2 μg/ml). This observation indicates that this compound most probably interferes with virus attachment. To elucidate if HHA is an ACE2 receptor inhibitor or an entry inhibitor which binds the virus, and prevent it in this way from interacting with its receptor, we pre-incubated HHA with either the SARS-CoV or with the cells. Pre-incubation of HHA with the virus did not provide inhibition of virus replication, nor did the pre-incubation of HHA with the cells. These pre-incubation experiments did not help us to understand the mechanism of action of the plant lectins.

Interestingly, the results of the extracellular viral RNA quantification also points to an intervention at a late step in the replication cycle around 5 h post-infection. Huang and colleagues observed that the presence of the spike protein in a pseudoparticle is necessary for budding and formation of a corona-like structure ([@bib13]). This indicates that the spike protein is likely to be important not only for viral attachment and fusion, but also for maturation and egress from cells. Earlier we demonstrated that one SARS-CoV replication cycle takes 6 h to complete in Vero E6 cells ([@bib16]). Therefore, inhibition of extracellular viral RNA-load up to 5 h post-infection suggests interference at the level of exocytosis or egress from the cell. Taken together, we could clearly demonstrate that the plant lectins interact both at virus entry and at virus release, a phenomenon that has never been observed for other viruses, including HIV.

In conclusion, we identified a variety of plant lectins as antiviral compounds against the SARS-CoV and the FIPV. The lectins most probably interfere with the glycans on the spike protein during virus entry and virus release. In view of the fact that the SARS-CoV discovery led to the identification of two new human coronaviruses, HCoV-NL63 and HCoV-HKU1, both of which are associated with serious lower respiratory diseases, the search for efficient anti-coronavirus compounds becomes more important. Our findings on the selective and potent anti-coronavirus activity of plant lectins should trigger further research on the discovery of other carbohydrate-binding agents, including synthetic low-molecular-weight compounds.
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[^1]: Monocot: Monocotyledoneae, dicot: Dicotyledoneae, Man: mannose, GlcNac: *N*-acetyl glucosamine, GalNAc: *N*-acetyl galactosamine, Gal: galactose, Neu5Ac: *N*-acetylneuraminic acid.

[^2]: Man: mannose, GlcNac: *N*-acetyl glucosamine, GalNAc: *N*-acetyl galactosamine, Gal: galactose, Neu5Ac: *N*-acetylneuraminic acid, na: no activity, ind: indeterminable.
